Scantox Ballerup ApS: Financial statements 2025
CVR: 34724938
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Scantox Ballerup ApS (CVR 34724938) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. That is a decrease of 28.7% compared with the year before. Equity in the 2025 report amounted to DKK -1,539,321. The company had 18 employees in the financial year.
- Gross Profit
- DKK 13,349,106
- Profit/Loss
- DKK -1,931,049
- Equity
- DKK -1,539,321
- Total Assets
- DKK 4,929,317
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 13.3M | -1.9M | -1.5M | 18 |
| 2024 | - | 18.7M | 255K | 391K | 20 |
| 2023 | - | 11.2M | 1.1M | 7M | 11 |
| 2022 | - | 14.1M | 4.7M | 10M | 9 |
| 2021 | - | 9.6M | 2.3M | 7.1M | 8 |
Official annual report
How creditworthy is Scantox Ballerup ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of December 1, 2025, Helle Kirstein Erichsen is registered as director of Scantox Ballerup ApS.
As of December 1, 2025, Ann Vivian Fullerton has stepped down as director of Scantox Ballerup ApS.
Scantox Ballerup ApS has published its annual report for 2024. Gross profit came to DKK 18,716,457, and the net result was DKK 255,010.
About Scantox Ballerup ApS
Scantox Ballerup ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SOLURAL PHARMA ApS. The management consists of Helle Kirstein Erichsen. The board consists of Jeanet Løgsted Nielsen (chair) and Emil Staal Bergander. The company is owned by Scantox Denmark ApS. The company has 14 employees (2026). In 2025, the company reported a gross profit of DKK 13,349,106 and a net result of DKK -1,931,049 compared with DKK 255,010 the year before. Equity in the 2025 report amounted to DKK -1,539,321.